Recently, a new study came out validating the efficacy of CBD in improving the quality of life for people with autism. The study, published in the medical journal Pharmaceuticals, revealed that CBD is found to be beneficial in reducing certain symptoms of Autism Spectrum Disorder, resulting in better quality of life. For the study, researchers analyzed 30 participants with autism. Their ages ranged from 5 to 18, and they were all given doses of CBD daily for 6 months.

Much like how cannabis legalization spread throughout North America, resulting in the growth of thousands of dispensaries and massive weed businesses and conglomerates alongside it, a few things need to happen first. Of course, psychedelics must be decriminalized and legalized. There have already been some cities/counties and states that have paved the way for decriminalizing psychedelics.

This new research expands upon an earlier Tilray study revealing a rising number of older patients seeking medical marijuana. The study identified chronic pain (27.8%), arthritis (14.9%), and anxiety (9%) as prevalent conditions prompting cannabis use among older adults. Pain emerged as the primary symptom, followed by anxiety and insomnia/sleep disorders.

Cannabis has also been shown to be an effective complementary tool that all cancer patients can benefit from. Integrating marijuana into a new, healthier lifestyle to combat cancer can be beneficial for pain relief, nausea and vomiting control, better sleep, improved appetite, and reduced inflammation. There are several studies to back it up, and now studies also show that cannabis use has been linked to a reduced risk in prostate cancer! 

However, a glimmer of hope has emerged from an unlikely source: cannabis. Some individuals with aphantasia have reported that after smoking or consuming cannabis, they suddenly gain the ability to visualize. This anecdotal evidence raises an intriguing question: could cannabis be a potential treatment for aphantasia?

Understanding how long marijuana stays in saliva i s crucial for various reasons, including legal concerns, workplace policies, and personal health decisions. Marijuana, derived from the cannabis plant, contains the psychoactive compound delta-9-tetrahydrocannabinol (THC), which can be detected in various bodily fluids, including saliva.

According to a recent study published in the journal, Frontiers in Psychiatry, microdosing magic mushrooms can help with focus and concentration, benefiting patients with ADHD. After all, disassociating and spacing out are some of the most common symptoms of ADHD.

The term "greening out" describes the uncomfortable or overindulgent state that might follow cannabis use. It is not fatal, but for those who encounter it, it can be upsetting. Greening out, also referred to as a cannabis-induced "overdose," can leave you feeling delusional and overwhelmed, like a roller coaster gone awry. But this is just a transitory state that will pass.

It turns out that psychedelics actually have emotional as well as psychological benefits for terminally ill patients. Anxiety about their final day, or general death anxiety, is just one of the most common yet debilitating concerns that the terminally ill have to contend with. They also face a wide range of mental and emotional issues that can make daily life difficult, especially as their illness progresses.

Recreational users go for DMT because it produces a strong, brief "trip," sometimes referred to as a "breakthrough in DMT." Although some studies point to possible advantages for both physical and mental health, the drug's adverse effects may offset these advantages.